Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
21.89
+0.24 (1.11%)
Mar 31, 2025, 3:57 PM EDT - Market open

AAPG Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Revenue
980.65221.98209.7127.9112.45
Upgrade
Revenue Growth (YoY)
341.77%5.85%651.38%124.18%-14.21%
Upgrade
Cost of Revenue
29.0930.54223.331.97
Upgrade
Gross Profit
951.57191.44187.7124.5810.48
Upgrade
Selling, General & Admin
383.12376.46328.02191.26130.34
Upgrade
Research & Development
947.25706.97743.1766.49564.57
Upgrade
Operating Expenses
1,3301,0831,071957.75694.91
Upgrade
Operating Income
-378.8-891.99-883.41-933.17-684.43
Upgrade
Interest Expense
-64.46-96.06-52.79-16.73-6.26
Upgrade
Interest & Investment Income
37.8432.419.737.115.22
Upgrade
Earnings From Equity Investments
-0.281.08-0.28--
Upgrade
Currency Exchange Gain (Loss)
6.691.62-2.649.9117.09
Upgrade
Other Non Operating Income (Expenses)
4.5820.7849.91139.4719
Upgrade
EBT Excluding Unusual Items
-394.42-932.17-879.48-793.41-649.38
Upgrade
Gain (Loss) on Sale of Investments
-0.83-0.7-9.77-20.89-3.75
Upgrade
Gain (Loss) on Sale of Assets
-02.07-0.03-
Upgrade
Other Unusual Items
----17.92-22.33
Upgrade
Pretax Income
-395.26-932.86-887.17-832.25-675.45
Upgrade
Income Tax Expense
10.43-7.15-4.25-49.832.16
Upgrade
Earnings From Continuing Operations
-405.68-925.71-882.92-782.42-677.61
Upgrade
Minority Interest in Earnings
0.250.08---
Upgrade
Net Income
-405.43-925.64-882.92-782.42-677.61
Upgrade
Net Income to Common
-405.43-925.64-882.92-782.42-677.61
Upgrade
Shares Outstanding (Basic)
302282264255216
Upgrade
Shares Outstanding (Diluted)
302282264255216
Upgrade
Shares Change (YoY)
7.00%7.07%3.56%17.93%84.97%
Upgrade
EPS (Basic)
-1.34-3.28-3.35-3.07-3.14
Upgrade
EPS (Diluted)
-1.34-3.28-3.35-3.07-3.14
Upgrade
Free Cash Flow
--772.19-857.2-1,040-859.88
Upgrade
Free Cash Flow Per Share
--2.73-3.25-4.08-3.98
Upgrade
Gross Margin
97.03%86.24%89.51%88.08%84.21%
Upgrade
Operating Margin
-38.63%-401.83%-421.25%-3343.50%-5497.42%
Upgrade
Profit Margin
-41.34%-416.98%-421.02%-2803.38%-5442.62%
Upgrade
Free Cash Flow Margin
--347.86%-408.75%-3726.60%-6906.64%
Upgrade
EBITDA
-299.63-812.82-835.99-915.99-667.46
Upgrade
EBITDA Margin
-30.55%----
Upgrade
D&A For EBITDA
79.1779.1747.4217.1816.97
Upgrade
EBIT
-378.8-891.99-883.41-933.17-684.43
Upgrade
EBIT Margin
-38.63%----
Upgrade
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q